• Reintam BlaserAnnikaA0000-0003-1211-7372Institute of Clinical Medicine, University of Tartu, Puusepa 8, 50406, Tartu, Estonia. annika.reintam.blaser@ut.ee.Department of Intensive Care Medicine, Lucerne Cantonal Hospital, Lucerne, Switzerland. annika.reint, Merli Mändul, Martin Björck, Stefan Acosta, Miklosh Bala, Zsolt Bodnar, Dumitru Casian, Zaza Demetrashvili, Mario D'Oria, Durán Muñoz-CruzadoVirginiaV0000-0003-4499-0483Virgen del Rocío University Hospital, Seville, Spain., Alastair Forbes, Hanne Fuglseth, Moran Hellerman Itzhaki, Benjamin Hess, Karri Kase, Mikhail Kirov, Kristoffer Lein, Matthias Lindner, Cecilia Inés Loudet, Damian J Mole, Marko Murruste, Alexandre Nuzzo, Sten Saar, Maximilian Scheiterle, Joel Starkopf, Peep Talving, Anna-Liisa Voomets, Kenneth K T Voon, Mohammad Alif Yunus, Kadri Tamme, and AMESI Investigators (Collaborators).
• Institute of Clinical Medicine, University of Tartu, Puusepa 8, 50406, Tartu, Estonia. annika.reintam.blaser@ut.ee.
• Crit Care. 2024 Jan 23; 28 (1): 3232.

BackgroundThe aim of this multicentre prospective observational study was to identify the incidence, patient characteristics, diagnostic pathway, management and outcome of acute mesenteric ischaemia (AMI).MethodsAll adult patients with clinical suspicion of AMI admitted or transferred to 32 participating hospitals from 06.06.2022 to 05.04.2023 were included. Participants who were subsequently shown not to have AMI or had localized intestinal gangrene due to strangulating bowel obstruction had only baseline and outcome data collected.ResultsAMI occurred in 0.038% of adult admissions in participating acute care hospitals worldwide. From a total of 705 included patients, 418 patients had confirmed AMI. In 69% AMI was the primary reason for admission, while in 31% AMI occurred after having been admitted with another diagnosis. Median time from onset of symptoms to hospital admission in patients admitted due to AMI was 24 h (interquartile range 9-48h) and time from admission to diagnosis was 6h (1-12 h). Occlusive arterial AMI was diagnosed in 231 (55.3%), venous in 73 (17.5%), non-occlusive (NOMI) in 55 (13.2%), other type in 11 (2.6%) and the subtype could not be classified in 48 (11.5%) patients. Surgery was the initial management in 242 (58%) patients, of which 59 (24.4%) underwent revascularization. Endovascular revascularization alone was carried out in 54 (13%), conservative treatment in 76 (18%) and palliative care in 46 (11%) patients. From patients with occlusive arterial AMI, revascularization was undertaken in 104 (45%), with 40 (38%) of them in one site admitting selected patients. Overall in-hospital and 90-day mortality of AMI was 49% and 53.3%, respectively, and among subtypes was lowest for venous AMI (13.7% and 16.4%) and highest for NOMI (72.7% and 74.5%). There was a high variability between participating sites for most variables studied.ConclusionsThe overall incidence of AMI and AMI subtypes varies worldwide, and case ascertainment is challenging. Pre-hospital delay in presentation was greater than delays after arriving at hospital. Surgery without revascularization was the most common management approach. Nearly half of the patients with AMI died during their index hospitalization. Together, these findings suggest a need for greater awareness of AMI, and better guidance in diagnosis and management.Trial RegistrationNCT05218863 (registered 19.01.2022).© 2024. The Author(s).

12 keywords...

hide…